Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
AbCellera has raised $200M in a funding round to support its biotechnology efforts following the Phase 2 results.
PRIVATEAug 12, 2026•about 4 hours ago
Amount Raised
$200 Million
Round Type
Venture - Series Unknown
VancouverBiotechnologyHealth CarePharmaceuticalDescription
AbCellera, a Vancouver-based biotech company, has successfully raised $200 million through a share offering. This funding will help support the company's ongoing research and development initiatives. The round comes in the wake of positive results in its Phase 2 trials. The investment showcases continued confidence in AbCellera's advancements in biotechnology.
Don't miss Ab Cellera's next move
Get an email the moment Ab Cellera raises, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
2 contactsVerified contactsCarl H., Infectious Disease
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech